Physiologically-based Pharmacokinetic Modelling for the Reduction of Animal Use in the Discovery of Novel Pharmaceuticals

By Thomas, Simon

The challenges of physiologically-based pharmacokinetic (PBPK) modelling and approaches to replacing the use of animals, in order to determine drug pharmacokinetics, are discussed. Reference is made to the limitations of in vivo animal studies in drug discovery. In particular, the ways in which animal studies contribute to drug attrition during the post-preclinical phase of testing are considered.



Issued: Dec. 2010

Journal Title: Alternatives to laboratory animals

ISSN: 0261-1929

Volume issue: 38 v. 1 no.

Pages: 81 - 85

Publisher: FRAME

AGRICOLA identifier: IND44585418
This page was updated on 11 February 2021
Did you find what you were looking for?
Yes, I found it! No, I did not!

Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.

What are you looking for?

We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!

Please contact us by email if you have any questions.

Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.

RadioButtonList field
 

Abonnér på nyhetsbrevene fra Norecopa